Area of research
Pulmonary and Respiratory Medicine · Immunology
Research interest
Research focused on TLR3 and Hepatocellular carcinoma, with related work in Survivin, Surgical oncology, Necroptosis. Notable publications include 'The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance', 'TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis', and 'High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway'.
Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort
Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis
High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway
Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases
Role of the prostaglandin E2 receptor agonists in TGF-β1-induced mesangial cell damage
TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis
TLR3 Plays Significant Roles against HBV-Associated HCC
Role of the ER stress in prostaglandin E2/E-prostanoid 2 receptor involved TGF-β1-induced mice mesangial cell injury
The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance
A Maladaptive Role for EP4 Receptors in Mouse Mesangial Cells
Role of the prostaglandin E2/E-prostanoid 2 receptor signalling pathway in TGFβ-induced mice mesangial cell damage
Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model
RETRACTED ARTICLE: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell
Expression and function of NET-1 in human skin squamous cell carcinoma
Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy<i>In Vitro</i>and<i>In Vivo</i>